Janet B. McGill

397 total papers · 28.3k total citations
235 papers, 16.1k citations indexed

About

Janet B. McGill is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Janet B. McGill has authored 235 papers receiving a total of 16.1k indexed citations (citations by other indexed papers that have themselves been cited), including 151 papers in Endocrinology, Diabetes and Metabolism, 53 papers in Cardiology and Cardiovascular Medicine and 48 papers in Surgery. Recurrent topics in Janet B. McGill's work include Diabetes Treatment and Management (90 papers), Diabetes Management and Research (89 papers) and Pancreatic function and diabetes (34 papers). Janet B. McGill is often cited by papers focused on Diabetes Treatment and Management (90 papers), Diabetes Management and Research (89 papers) and Pancreatic function and diabetes (34 papers). Janet B. McGill collaborates with scholars based in United States, Denmark and Germany. Janet B. McGill's co-authors include Irl B. Hirsch, Robert D. Toto, Guillermo E. Umpierrez, Daniel Einhorn, Dick de Zeeuw, George Grunberger, Richard M. Bergenstal, Roy W. Beck, Jeffrey I. Mechanick and Patrick J. Lustman and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and JAMA.

In The Last Decade

Janet B. McGill

224 papers receiving 15.3k citations

Hit Papers

A Trial of Darbepoetin Al... 2004 2026 2011 2018 2009 2017 2004 2017 2020 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation benchmark for papers published in the same subfield and year, or reaches the top citation threshold in at least one of its specific research topics.

  1. A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease
    2009 1.4k citations Marc A. Pfeffer, Emmanuel A. Burdmann et al. New England Journal of Medicine profile →
  2. Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections
    2017 829 citations Roy W. Beck, Tonya D. Riddlesworth et al. JAMA profile →
  3. Metabolic Effects of Carvedilol vs Metoprolol in Patients With Type 2 Diabetes Mellitus and Hypertension
    2004 536 citations George L. Bakris, Vivian Fonseca et al. JAMA profile →
  4. Continuous Glucose Monitoring Versus Usual Care in Patients With Type 2 Diabetes Receiving Multiple Daily Insulin Injections
    2017 438 citations Roy W. Beck, Tonya D. Riddlesworth et al. Annals of Internal Medicine profile →
  5. Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm – 2020 Executive Summary
    2020 407 citations Alan J. Garber, Yehuda Handelsman et al. Endocrine Practice profile →
  6. Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm – 2018 Executive Summary
    2018 377 citations Alan J. Garber, Martin J. Abrahamson et al. Endocrine Practice profile →
  7. Evidence of a Strong Association Between Frequency of Self-Monitoring of Blood Glucose and Hemoglobin A1c Levels in T1D Exchange Clinic Registry Participants
    2013 363 citations Kellee M. Miller, Roy W. Beck et al. Diabetes Care profile →
  8. Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive type 2 Diabetes Management Algorithm – 2017 Executive Summary
    2017 326 citations Alan J. Garber, Martin J. Abrahamson et al. Endocrine Practice profile →
  9. Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm – 2019 Executive Summary
    2019 225 citations Alan J. Garber, Martin J. Abrahamson et al. Endocrine Practice profile →
  10. Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes
    2025 33 citations Rajiv Agarwal, Jennifer B. Green et al. New England Journal of Medicine profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Janet B. McGill 9.0k 3.4k 3.0k 2.4k 2.2k 235 16.1k
Michel Marre 8.6k 1.0× 3.3k 1.0× 3.7k 1.3× 3.9k 1.6× 2.3k 1.0× 422 17.0k
Mikhail Kosiborod 12.0k 1.3× 4.3k 1.2× 9.1k 3.0× 3.3k 1.4× 1.8k 0.8× 427 21.7k
Michael W. Steffes 7.2k 0.8× 4.2k 1.2× 3.4k 1.1× 2.4k 1.0× 5.6k 2.5× 154 19.6k
François Cambien 7.0k 0.8× 3.2k 0.9× 10.0k 3.3× 3.9k 1.6× 837 0.4× 229 20.8k
Lise Tarnow 5.2k 0.6× 1.8k 0.5× 4.1k 1.4× 2.1k 0.9× 2.9k 1.3× 279 12.1k
H. Keen 9.1k 1.0× 2.8k 0.8× 3.5k 1.2× 2.0k 0.8× 3.1k 1.4× 260 16.4k
George Jerums 4.7k 0.5× 1.3k 0.4× 2.7k 0.9× 2.1k 0.9× 4.8k 2.2× 285 13.4k
Guntram Schernthaner 6.2k 0.7× 2.7k 0.8× 1.4k 0.5× 2.9k 1.2× 1.0k 0.5× 227 10.9k
Ian H. de Boer 6.5k 0.7× 3.1k 0.9× 3.8k 1.3× 2.4k 1.0× 7.7k 3.5× 324 20.0k
Andrzej S. Królewski 5.7k 0.6× 3.2k 0.9× 2.5k 0.9× 3.1k 1.3× 5.2k 2.4× 190 15.6k

Countries citing papers authored by Janet B. McGill

Since Specialization
Citations

This map shows the geographic impact of Janet B. McGill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Janet B. McGill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Janet B. McGill more than expected).

Fields of papers citing papers by Janet B. McGill

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Janet B. McGill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Janet B. McGill. The network helps show where Janet B. McGill may publish in the future.

Co-authorship network of co-authors of Janet B. McGill

This figure shows the co-authorship network connecting the top 25 collaborators of Janet B. McGill. A scholar is included among the top collaborators of Janet B. McGill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Janet B. McGill. Janet B. McGill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Loading papers...

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mark Rounsevell Breakdown of academic impact, for papers by Alan M. Krensky Breakdown of academic impact, for papers by Francesco Cosentino Breakdown of academic impact, for papers by A. Bressan Breakdown of academic impact, for papers by Eray S. Aydil Breakdown of academic impact, for papers by Frank F. Furstenberg Breakdown of academic impact, for papers by Jian Tian Breakdown of academic impact, for papers by Srinivasa T. Reddy
Rankless by CCL
2026